Zi-Xuan Wang

Zi-Xuan Wang

Auto-generated profile, based on publicly available information

Zi-Xuan Wang

Institute of Molecular Medicine and Oncology, Chongqing Medical University, Chongqing, China

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2026 in Balkan Medical Journal
Verified
Journal Article
Open access
ZTZi-Xin Tian
Zi-Xin Tian
JZJun Zhang
Jun Zhang
ZWZi-Xuan Wang
Zi-Xuan Wang
XSXi Song
Xi Song
YZYi-Tao Zhou
Yi-Tao Zhou
YHYing-Yi Hu
Ying-Yi Hu
Background: Aberrations in cadherin-related 23 (CDH23) account for a significant proportion of familial autosomal recessive non-syndromic hearing loss (DFNB12), a common subtype of hereditary hearing loss worldwide. Aims: This study aimed to elucidate the molecular basis and pathogenic mechanism of DFNB12 in an affected girl from a nine-member pedigree. Study Design: Family-based genetic study with pedigree analysis. Methods: Clinical whole-exome sequencing combined with pedigree analysis was used to identify disease-causing mutations. The potential functional consequences of these mutations were investigated using structural bioinformatic approaches, including homology modeling, molecular dynamics simulations, and other relevant tools. Results: The proband carried compound heterozygous variants: a known pathogenic maternal variant (c.6049G > A) and a paternal haplotype comprising two linked variants (c.3262G > A and c.6911G > A), each individually classified as benign. Pedigree segregation analysis demonstrated that the paternal haplotype acts as a single pathogenic allele. Conclusion: Two individually benign variants can combine to form a novel pathogenic haplotype (c.3262A–c.6911A). This mechanism may be under-recognized in routine variant interpretation pipelines. Our findings underscore the importance of evaluating the combined effects of linked benign variants to ensure accurate genetic counseling.